The OxyContin maker filed its long-awaited restructuring plan in bankruptcy court. Revenue from the new company would go exclusively to abating the opioid crisis.The OxyContin maker filed its long-awaited restructuring plan in bankruptcy court. Revenue from the new company would go exclusively to abating the opioid crisis.Suits and Litigation (Civil), Bankruptcies, Opioids and Opiates, OxyContin (Drug), Purdue Pharma, Sackler FamilyRead More
